MDC is a national Life Sciences service dedicated to turning drug discovery into commercial breakthroughs. The Bionow business award recognises MDC’s commitment, professionalism, creativity and success in providing specialist support to the Life Sciences sector.
At the frontier of drug discovery, MDC works with entrepreneurial scientists to validate ideas through its expertise, data, insights and technology, giving them the best chance of commercial success.
Companies supported by MDC have gone on to raise over £1.24bn in R&D investment – increasing jobs, improving productivity, and cementing the UK’s position as a world leader in Life Sciences.
MDC’s approach to drug discovery drives game-changing breakthroughs and improves patients’ lives.
Professor Chris Molloy, CEO of Medicines Discovery Catapult, said:
“MDC is in service to our sector, supporting the nation’s most entrepreneurial scientists to ensure that their every move counts, wherever they are. We are humbled and grateful to receive this award from this community in recognition of the momentum we provide to those who take the risk to innovate in drug discovery – right across our nation – and improve patient lives. Working in close collaboration with our regional and national partners, we will continue to improve commercial success for all our regions, feeding insights back into the sector and reshaping UK drug discovery for the benefit of patients everywhere.”
Bionow is a not-for-profit membership organisation supporting the biomedical, pharma and life sciences sectors across North England.
For a full list of all of the winners at last night’s ceremony, visit the Bionow website >
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
Dr Emma Jones, a Lead Scientist in in vitro Neurobiology at Medicines Discovery Catapult (MDC), has contributed to a new children’s book celebrating the diversity of careers in science.
Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.
